secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001493152-25-015997
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim enters up to $500M equity facility with Chardan Capital Markets
---------------------------------------------------------------------

- Sonim may sell up to $500M in common stock to Chardan over 36 months at VWAP minus 3.5% discount.
- Exchange cap of 2,066,747 shares (19.99% outstanding) unless shareholder approval or price condition met.
- Minimum 33% of proceeds must prepay $2.755M note to Streeterville Capital, LLC issued July 11, 2025.
- No restrictions on future financings; Chardan prohibits short sales and hedging.
- Company can terminate with 10 trading days notice; Chardan terminates on customary events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000149315225015997/0001493152-25-015997-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000149315225015997/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-015997

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer